These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future. Allen LV Int J Pharm Compd; 2017; 21(4):293-298. PubMed ID: 28719372 [TBL] [Abstract][Full Text] [Related]
4. Basics of Sterile Compounding: Excipients Used in Injections. Akers MJ Int J Pharm Compd; 2017; 21(4):301-308. PubMed ID: 28719373 [TBL] [Abstract][Full Text] [Related]
5. Basics of sterile compounding: unique and special characteristics of sterile dosage forms. Akers MJ Int J Pharm Compd; 2014; 18(6):479-84. PubMed ID: 25906625 [TBL] [Abstract][Full Text] [Related]
6. Design and operation of a new sterile manufacturing facility. Fornabaio TA Bull Parenter Drug Assoc; 1970; 24(3):110-8. PubMed ID: 5422900 [No Abstract] [Full Text] [Related]
7. THE FORMULATION AND MANUFACTURING OF STERILE PHARMACEUTICAL PRODUCTS. KIRSCH NC Pharm Weekbl; 1965 Mar; 100():413-28. PubMed ID: 14330876 [No Abstract] [Full Text] [Related]
8. Increasing Patient Safety by Closing the Sterile Production Gap-Part 1. Introduction. Agalloco JP PDA J Pharm Sci Technol; 2017; 71(4):261-268. PubMed ID: 28089964 [TBL] [Abstract][Full Text] [Related]
9. Increasing Patient Safety by Closing the Sterile Production Gap-Part 2. Implementation. Agalloco JP PDA J Pharm Sci Technol; 2017; 71(4):269-273. PubMed ID: 28089965 [TBL] [Abstract][Full Text] [Related]
10. High throughput formulation: strategies for rapid development of stable protein products. Nayar R; Manning MC Pharm Biotechnol; 2002; 13():177-98. PubMed ID: 11987752 [No Abstract] [Full Text] [Related]
11. [ON THE VALUE AND TESTING OF DRUGS]. BUECHI J Pharm Acta Helv; 1964 Feb; 39():65-76. PubMed ID: 14224305 [No Abstract] [Full Text] [Related]